TY - JOUR
T1 - A single subset of dendritic cells controls the cytokine bias of natural killer T cell responses to diverse glycolipid antigens
AU - Arora, Pooja
AU - Baena, Andres
AU - Yu, Karl O.A.
AU - Saini, Neeraj K.
AU - Kharkwal, Shalu S.
AU - Goldberg, Michael F.
AU - Kunnath-Velayudhan, Shajo
AU - Carreño, Leandro J.
AU - Venkataswamy, Manjunatha M.
AU - Kim, John
AU - Lazar-Molnar, Eszter
AU - Lauvau, Gregoire
AU - Chang, Young tae
AU - Liu, Zheng
AU - Bittman, Robert
AU - Al-Shamkhani, Aymen
AU - Cox, Liam R.
AU - Jervis, Peter J.
AU - Veerapen, Natacha
AU - Besra, Gurdyal S.
AU - Porcelli, Steven A.
N1 - Funding Information:
This work was supported by NIH/NIAID grant AI45889 to S.A.P. Flow cytometry and imaging studies were carried out with analytical imaging and FACS core facilities supported by the Einstein Cancer Center (NIH/NCI CA013330) and the Einstein Center for AIDS Research (NIH AI-51519). S. pneumoniae URF918 was provided by M. Kronenberg (La Jolla Institute for Allergy & Immunology). G.S.B was supported by a Personal Research Chair from James Bardrick, a Royal Society Wolfson Research Merit Award, the Wellcome Trust (084923/B/08/7), and the MRC (G1001750). A.B. acknowledges support from Programa Estrategia de Sostenibilidad, Universidad de Antioquia, Medellín, Colombia. S.A.P. has served as paid consultants for Vaccinex, which has an interest in the commercial development of iNKT cell targeted therapeutics. We thank Olisambu Uche for help with FACS sorting.
PY - 2014/1/16
Y1 - 2014/1/16
N2 - Many hematopoietic cell types express CD1d and are capable of presenting glycolipid antigens to invariant natural killer Tcells (iNKT cells). However, the question of which cells are the principal presenters of glycolipid antigens invivo remains controversial, and it has been suggested that this might vary depending on the structure of a particular glycolipid antigen. Here we have shown that a single type of cell, the CD8α+ DEC-205+ dendritic cell, was mainly responsible for capturing and presenting a variety of different glycolipid antigens, including multiple forms of α-galactosylceramide that stimulate widely divergent cytokine responses. After glycolipid presentation, these dendritic cells rapidly altered their expression of various costimulatory and coinhibitory molecules in a manner that was dependent on the structure of the antigen. These findings show flexibility in the outcome of two-way communication between CD8α+ dendritic cells and iNKT cells, providing a mechanism for biasing toward either proinflammatory or anti-inflammatory responses.
AB - Many hematopoietic cell types express CD1d and are capable of presenting glycolipid antigens to invariant natural killer Tcells (iNKT cells). However, the question of which cells are the principal presenters of glycolipid antigens invivo remains controversial, and it has been suggested that this might vary depending on the structure of a particular glycolipid antigen. Here we have shown that a single type of cell, the CD8α+ DEC-205+ dendritic cell, was mainly responsible for capturing and presenting a variety of different glycolipid antigens, including multiple forms of α-galactosylceramide that stimulate widely divergent cytokine responses. After glycolipid presentation, these dendritic cells rapidly altered their expression of various costimulatory and coinhibitory molecules in a manner that was dependent on the structure of the antigen. These findings show flexibility in the outcome of two-way communication between CD8α+ dendritic cells and iNKT cells, providing a mechanism for biasing toward either proinflammatory or anti-inflammatory responses.
UR - http://www.scopus.com/inward/record.url?scp=84892451751&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84892451751&partnerID=8YFLogxK
U2 - 10.1016/j.immuni.2013.12.004
DO - 10.1016/j.immuni.2013.12.004
M3 - Article
C2 - 24412610
AN - SCOPUS:84892451751
SN - 1074-7613
VL - 40
SP - 105
EP - 116
JO - Immunity
JF - Immunity
IS - 1
ER -